HOME >> MEDICINE >> NEWS
Mayo Clinic research shows young people who died suddenly and inexplicably had genetic heart defects

the heart's electrical system."

The Mayo Clinic report appears as the featured article and editorial topic in the Jan. 16, 2007, issue of the Journal of the American College of Cardiology.

Significance of the Mayo Clinic Research

These results identify a tragic situation that could, with increased medical surveillance, potentially be prevented in many cases. To do so requires physicians and families to work astutely together to take a careful multigenerational heart history. Dr. Ackerman says that to identify at-risk relatives, all immediate family members of the person who died inexplicably must undergo comprehensive cardiac evaluation that includes, at a minimum, an electrocardiogram and an exercise stress test as initial screens for LQTS and CPVT.

If evidence of heart problems is found, family members need to act immediately by getting screened for the lethal mutations, and treated, if necessary, he says.

"Families who have lost a loved one to sudden unexplained death should now know that they can do more if the coroner or medical examiner is unable to provide an explanation for their loved one's sudden and unexplained death," Dr. Ackerman says. "Postmortem genetic testing could be performed on the victim of sudden death in search of the cause. Now, one-third of the time, we can find the cause."

Warning Signs

To prevent these kinds of sudden unexplained deaths, family members and physicians must be alert to -- and act on -- warning signs of a heart condition. Although all deaths in the study were officially categorized as unexplained, the medical histories showed that nearly half of those with the lethal mutations had experienced a warning sign prior to death.

Warning signs of possible mutation-linked heart abnormality include:

  • sudden fainting or a sudden seizure.

  • evidence of unexplained death in the family history, such as a moto
    '"/>


Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
30-Jan-2007


Page: 1 2 3

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. New Mayo Clinic MRI technology enables noninvasive liver diagnoses
6. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
7. Elsevier launches the Clinics on ScienceDirect
8. Clinical guidelines for blood conservation during cardiac procedures developed
9. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
10. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
11. Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression

Post Your Comments:
(Date:5/20/2013)... May 20, 2013 The Multiple System ... the launch of its new Multiple System Atrophy ... few years, The MSA Coalition’s grass roots fundraising has ... mission beyond patient/caregiver support to now include education, advocacy ... all donations received by The Coalition go directly into ...
(Date:5/20/2013)... 2013 Gilman Law LLP, a leading ... Byetta lawsuits, is troubled by a new study that ... similar type 2 diabetes drugs are growing. The ... (ISMP), found that 71 Byetta pancreatic cancer reports had ... (FDA) as of June 30, 2012. Overall, ...
(Date:5/20/2013)... Dalton, Georgia (PRWEB) May 20, 2013 ... fields, has significantly expanded its presence in the Midwest ... office in Kansas City, Missouri. Sporturf Midwest is ... focus on Iowa, Nebraska, Missouri and Kansas. , ... Sporturf has not really been in before,” noted Shonk. ...
(Date:5/20/2013)... May 20, 2013 Headquartered in New ... Levy Phillips & Konigsberg LLP (“LPK”) has recently ... Plains, New York. LPK will better serve people suffering ... Valley, including Westchester, Putnam, Rockland, Orange, and Dutchess counties. ... by asbestos-related diseases throughout New York, New Jersey, and ...
(Date:5/20/2013)... VA (PRWEB) May 20, 2013 Orthopaedic ... successfully performed a procedure using SpineFrontier’s FacetFuse Screw System ... System. The operation took place on Tuesday, April ... Newport News, VA. The surgery was a facet ... year-old, female patient. , Dr. Carlson described the case, ...
Breaking Medicine News(10 mins):Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 2Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 3Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 5Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 3Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 2Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 3
(Date:5/20/2013)... , May 20, 2013 Sequent Medical, Inc. ... the SL ("Single Layer") family of WEB ® ... of these new models in select neurovascular centers in ... superior navigability that will enable physicians to treat a ... The SL configurations are made possible by further ...
(Date:5/20/2013)... , Kalifornien, 20. Mai 2013 /PRNewswire/ ... dass das Unternehmen die CE-Kennzeichnung für die ... Embolisation von Aneurysmen erhalten hat. Das Unternehmen ... bereits mit der kontrollierten Einführung dieser neuen ... die SL-Produktfamilie auch ein verbessertes Handling, das ...
(Date:5/20/2013)... --  Life Technologies Corporation (NASDAQ: LIFE ... and 3500xL Dx Genetic Analyzers have been approved by ... Mexico for diagnostic use.  The ... to serve the clinical end market in ... -based solutions.  The Applied Biosystems™ 3500 ...
Breaking Medicine Technology:Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3
Cached News: